Lee I - Search Results

1

E2F-1 is a critical modulator of cellular senescence in human cancer.

Park C, Lee I, Kang WK. Park C, et al. Among authors: lee i. Int J Mol Med. 2006 May;17(5):715-20. Int J Mol Med. 2006. PMID: 16596252

2

Neolignans from Saururus chinensis inhibit PC-3 prostate cancer cell growth via apoptosis and senescence-like mechanisms.

Song SY, Lee I, Park C, Lee H, Hahm JC, Kang WK. Song SY, et al. Among authors: lee i, lee h. Int J Mol Med. 2005 Oct;16(4):517-23. Int J Mol Med. 2005. PMID: 16142381

3

Lovastatin-induced RhoA modulation and its effect on senescence in prostate cancer cells.

Lee J, Lee I, Park C, Kang WK. Lee J, et al. Among authors: lee i. Biochem Biophys Res Commun. 2006 Jan 20;339(3):748-54. doi: 10.1016/j.bbrc.2005.11.075. Biochem Biophys Res Commun. 2006. PMID: 16316623

4

Influence of small interfering RNA corresponding to ets homologous factor on senescence-associated modulation of prostate carcinogenesis.

Park C, Lee I, Kang WK. Park C, et al. Among authors: lee i. Mol Cancer Ther. 2006 Dec;5(12):3191-6. doi: 10.1158/1535-7163.MCT-06-0570. Mol Cancer Ther. 2006. PMID: 17172423

5

Inhibitory role of RhoA on senescence-like growth arrest by a mechanism involving modulation of phosphatase activity.

Park C, Lee I, Jang JH, Kang WK. Park C, et al. Among authors: lee i. FEBS Lett. 2007 Aug 7;581(20):3800-4. doi: 10.1016/j.febslet.2007.07.007. Epub 2007 Jul 16. FEBS Lett. 2007. PMID: 17658517 Free article.

6

A novel senescence-evasion mechanism involving Grap2 and Cyclin D interacting protein inactivation by Ras associated with diabetes in cancer cells under doxorubicin treatment.

Lee I, Yeom SY, Lee SJ, Kang WK, Park C. Lee I, et al. Among authors: lee sj. Cancer Res. 2010 Jun 1;70(11):4357-65. doi: 10.1158/0008-5472.CAN-09-3791. Epub 2010 May 11. Cancer Res. 2010. PMID: 20460530

7

Knockdown of inwardly rectifying potassium channel Kir2.2 suppresses tumorigenesis by inducing reactive oxygen species-mediated cellular senescence.

Lee I, Park C, Kang WK. Lee I, et al. Mol Cancer Ther. 2010 Nov;9(11):2951-9. doi: 10.1158/1535-7163.MCT-10-0511. Epub 2010 Sep 14. Mol Cancer Ther. 2010. PMID: 20841375

8

Inhibition of monocarboxylate transporter 2 induces senescence-associated mitochondrial dysfunction and suppresses progression of colorectal malignancies in vivo.

Lee I, Lee SJ, Kang WK, Park C. Lee I, et al. Among authors: lee sj. Mol Cancer Ther. 2012 Nov;11(11):2342-51. doi: 10.1158/1535-7163.MCT-12-0488. Epub 2012 Sep 10. Mol Cancer Ther. 2012. PMID: 22964484

9

TPK1 as a predictive marker for the anti-tumour effects of simvastatin in gastric cancer.

Hong JY, Kim HJ, Kim K, Hong J, Kim JE, Byeon SJ, Lee IK, Kim KM, Shim M, Park SH, Park JO, Park YS, Lim HY, Kim ST, Lee J, Kang WK. Hong JY, et al. Pathol Res Pract. 2020 Mar;216(3):152820. doi: 10.1016/j.prp.2020.152820. Epub 2020 Jan 10. Pathol Res Pract. 2020. PMID: 31964553

10

Comprehensive pharmacogenomic characterization of gastric cancer.

Sa JK, Hong JY, Lee IK, Kim JS, Sim MH, Kim HJ, An JY, Sohn TS, Lee JH, Bae JM, Kim S, Kim KM, Kim ST, Park SH, Park JO, Lim HY, Kang WK, Her NG, Lee Y, Cho HJ, Shin YJ, Kim M, Koo H, Kim M, Seo YJ, Kim JY, Choi MG, Nam DH, Lee J. Sa JK, et al. Genome Med. 2020 Feb 18;12(1):17. doi: 10.1186/s13073-020-0717-8. Genome Med. 2020. PMID: 32070411 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,339 results

Search Page